XTalks

DECEMBER 29, 2022

For example, on the pharma and biotech side, there has been growing demand for new drugs and biologics, from new classes of dual-action diabetes and weight loss drugs like Ozempic and Mounjaro to life-saving gene therapies. 1. Cell and Gene Therapies.

Life Science 52

Life Science Gene Therapy Gene Manufacturing 52

Pharmaceutical Technology

JANUARY 31, 2023

FDA director Robert Califf gave his prognosis for the pharma industry at this year’s JP Morgan Healthcare Conference in San Francisco over January 9–12. That leaves three years for pharma companies to prepare. asked panel chair Ipsita Smolinski, MD of consultancy Capitol Street. It’s much needed. It’s a hot area.”

Drugs 130

Drugs Regulation Gene Therapy Insulin 130

Drug Discovery World

JANUARY 26, 2023

As such, 2022 saw a marked fall in ROI for global pharmaceutical companies and their research and development activities. According to research from Deloitte 1 , the average ROI in R&D for global pharma companies fell to just 1.2% We are seeing the change from traditional biopharmaceuticals to cell and gene therapies.

Development 98

Development Drugs Clinical Trials Clinical Trials 98

Drug Discovery World

MAY 6, 2024

A more established Amsterdam-based enterprise is gene therapy company uniQure, developer of etranacogene dezaparvovec, the first gene therapy for haemophilia B, which was approved for use in the US in November 2022 and in the EU in February 2023.

Drugs 59

Drugs Life Science Gene Editing Gene 59

pharmaphorum

NOVEMBER 30, 2022

The biggest gathering of pharma companies in Europe right now on the commercial side, the Veeva Systems Summit permits the sharing of best practices and of new ideas. Facts that they gleaned included: Across Europe, only 52% of HCPs will accept a visit from a pharma company (i.e.

Life Science 93

Life Science Pharma Companies Sales Marketing 93

pharmaphorum

APRIL 28, 2022

Although they have, by definition, small addressable markets, the treatments cost just as many resources to develop as therapies for more common diseases – sometimes more, because of the added difficulty of finding sufficiently large patient populations for trials and finding disease experts to run them. How big pharma tackles rare diseases.

Pharma Companies 57

Pharma Companies Branding Development Marketing 57

pharmaphorum

MARCH 22, 2022

The efforts underway to strengthen the manufacturing process across the industry have become more important than ever, as the therapies the industry is developing increase in complexity. Furthermore, he highlighted the regulated nature of the pharma manufacturing process as being one that made AR training intervention even more valuable.

Manufacturing 129

Manufacturing Production Contamination Gene Therapy 129

Drug Discovery World

SEPTEMBER 28, 2022

Its application in pharma, most commonly in drug discovery, has been steadily growing with global partnerships between tech vendors and pharma companies becoming more commonplace. Biotech and AI companies founded by purely tech professionals often opt to bring in pharma executives with insider knowledge further down the line.

Pharma Companies 52

Pharma Companies Drugs In-Vivo Genetics 52

The Pharma Data

DECEMBER 30, 2020

The reason for this is still not understood and many regulators may want it to be explained before authorizing it for broader use. It is a strong potential player in the gene therapy space. billion, Regenxbio is also a gene therapy company. Johnson & Johnson’s COVID-19 vaccine.

Vaccination 52

Vaccination Vaccine Gene Therapy Trials 52

XTalks

MARCH 22, 2023

While not a record-breaking deal at $17 billion, the buyout strengthened Pfizer’s injectables business unit with the company reporting an 11 percent increase in revenue the following year. And drugmakers are using their R&D expenditure to justify setting astronomically high list prices for new therapies.

Life Science 97

Life Science Drugs FDA Approval Vaccination 97

pharmaphorum

SEPTEMBER 1, 2020

.” This public-spirited industry still required greater oversight, however, and government regulations on medicines increased on both sides of the Atlantic. Thalidomide and the development of drug safety regulation and monitoring. George Merck on the cover of Time magazine.

Medicine 145

Medicine Insulin Pharmacy Drugs 145

The Pharma Data

DECEMBER 17, 2020

Smith joined SpringWorks at the company’s inception in 2017 and was a founding member of the management team. Prior to SpringWorks, Smith was the executive vice president of Gene Therapy at Bamboo Therapeutics. AB2 Bio – Swiss pharma company AB2 Bio Ltd. Immune Regulation – U.K.-based

Development 52

Development Gene Therapy Engineer Life Science 52

Drug Discovery World

MARCH 29, 2023

The commission is looking to put more pressure on pharma companies to report such shortages, and to offer a drug’s marketing authorisation to another company before withdrawing it from the market. She also does not believe that the problems with Europe’s medicines can be solved with regulation.

Clinical Trials 52

Clinical Trials Clinical Trials Production Medicine 52

pharmaphorum

NOVEMBER 23, 2022

We looked at the areas of rare diseases, cell and gene therapy, vaccines – loads of different perspectives. There is still a struggle in pharma, an increasing demand for promotional materials. But it’s a highly regulated industry, with significant risks associated with any non-compliant material that’s been approved.

Life Science 96

Life Science Marketing Medicine Production 96

Delveinsight

FEBRUARY 14, 2021

The health regulatory agencies all over have issued several guidelines, released strategies, and amended regulations to expedite the drug delivery process in the rare disease market landscape.

Marketing 52

Marketing Clinical Trials Clinical Trials Trials 52